Medexus Pharmaceuticals Inc. (TSE:MDP – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as C$5.10 and last traded at C$5.10, with a volume of 128735 shares changing hands. The stock had previously closed at C$5.10.
Medexus Pharmaceuticals Price Performance
The stock has a fifty day moving average price of C$4.02 and a 200-day moving average price of C$3.38. The company has a market cap of C$161.47 million, a PE ratio of -72.86 and a beta of 0.53.
Medexus Pharmaceuticals Company Profile
Medexus is a leading specialty pharmaceutical company with a strong North American commercial platform and a growing portfolio of innovative and rare disease treatment solutions. Medexus’s current focus is on the therapeutic areas of hematology and hematology-oncology and rheumatology and allergy.
Read More
- Five stocks we like better than Medexus Pharmaceuticals
- AirJoule Unveils Prime System, Clearing Path to Commercialization
- Copper Stocks Are Getting a Bigger Spotlight as Gold’s Rally Cracks
- Nike Q4 Beat Masks Core Weakness as Analysts Cut Price Targets
- Uber’s Waymo Detour Tests the Stock’s Robotaxi Bull Case
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
